[1]Virag JA, Rolle ML, Reece J, et al. Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function[J]. Am J Pathol, 2007, 71(5):1431-1440.
[2]Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies[J]. Tissue Eng, 2001,7(2):211-228.
[3]Moscoso I, Centeno A, López E, et al. Differentiation “in vitro” of primary and immortalised porcine mesenchymal stem cells into cardiomyocytes for cell transplantation[J]. Transplant Proc, 2005,37(1):481-482.
[4]Li N, Huang R, Zhang X,et al.Stem cells cardiac patch from decellularized umbilical artery improved heart function after myocardium infarction[J].Biomed Mater Eng, 2017,28(s1):S87-S94
[5]Ah EU, Senst C, Murthy SN, et al. Aging alters tissue resident mesenchymal stem cell properties[J]. Stem Cell Res, 2012,8(2): 215-225.
[6]Vishnubalaji R, Al-Nbaheen M, Kadalmani B, et al. Comparative investigation of the differentiation capability of bone-marrow- and adipose-derived mesenchymal stem cells by qualitative and quantitative analysis[J]. Cell Tissue Res, 2012,347(2):419-427.
[7]Minguell JJ, Erices A, Conget P. Mesenchymal stem cells[J]. Exp Biol Med, 2001,226(6): 507-520.
[8]Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells (The International Society for Cellular Therapy position statement)[J]. Cytotherapy, 2006,8(4):315-317.
[9]Hamid T, Prabhu SD. Immunomodulation is the key to cardiac repair[J]. Circu Res, 2017,120(10):1530-1532.
[10]Psaltis PJ, Zannettino AC, Worthley SG, et al. mesenchymal stromal cells: potential for cardiovascular repair[J]. Stem Cells, 2008,26(9):2201-2210.
[11]Richardson JD, Psaltis PJ, Frost L, et al. Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction[J]. Cytotherapy, 2014,16(4):460-470.
[12]Li Q, Guo ZK, Chang YQ, et al.Gata4, Tbx5 and Baf60c induce differentiation of adipose tissue-derived mesenchymal stem cells into beating cardiomyocytes[J]. Int J Biochem Cell Biol,2015, 66:30-36.
[13]Aceves JL, Archundia A. Stem cell perspectives in myocardial infarctions[J]. Rev Invest Clin, 2005,57(2):156-162.
[14]Tomita S, Li RK, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function[J]. Circulation, 1999,100(19 Suppl):Ⅱ247-256.
[15]Pijnappels DA, Schalij MJ, Ramkisoensing AA, et al. Forced alignment of mesenchymal stem cells undergoing cardiomyogenic differentiation affects functional integration with cardiomyocyte cultures[J]. Circ Res, 2008,103(2):167-176.
[16]Qi LJ, Guo K, Li Q, et al. The effect of three methods about inducing CD73+ mesenchymal stem cells into cardiomyocytes[J]. J Anat, 2013,44(3):339-344.
[17]Orlic D, Kajstura J, Chimenti S, et al. Transplanted adult bone marrow cells repair myocardical infarcts in mice[J]. Ann N Y Acad Sci, 2001,938:221-229.
[18]Ieda M, Tsuchihashi T, Ivey KN, et al.Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling[J]. Dev Cell, 2009,16(2), 233-244.
|